Abbott Laboratory (ABOT) Stock Price and Company Financials
Rs. 927.73
Rs. 10.27 (1.11%)
Last updated: 2026-09-28
Annual Financials (Latest Year: 2025)
SalesRs. 75,397,732,000
Total revenue generated from core business operations during the year.
Profit After TaxRs. 7,966,500,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)Rs. 81.37
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin35.08%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin10.57%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth52.21%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.
*Annual figures from latest financial statement
| Open | Close | Low | High | Volume |
|---|---|---|---|---|
| 938.00 | 927.73 | 920.00 | 938.00 | 1,892 |